ArticleFrontiers in aging neuroscience2026
Stereological sampling-based estimates of dopaminergic and cholinergic neuron numbers in young adult and aged male and female Fischer 344 × Brown Norway F1 hybrid rats.
Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Age is the primary risk factor for neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease, which are characterized by profound loss of midbrain dopaminergic neurons and basal forebrain cholinergic neurons, respectively. In addition, loss of these neurons can occur even in "normal" (i.e., non-pathological) aging, and as a result there is growing recognition of the value of aged animals in studying both normal aging and age-related neurodegenerative disease. The Fischer 344 x Brown Norway F1 hybrid (FBN) rat is commonly used for such purposes and is recommended for use in aging studies by the NIH due to its extended lifespan and more accurate representation of age-related human diseases such as sarcopenia and cognitive decline. Despite the significant value and broad use of this model, dopaminergic and cholinergic neurons have not been well characterized in this strain, and there have been even fewer comparisons between males and females. To address this issue, we used systematic random sampling principles to generate population estimates for dopaminergic neurons in the substantia nigra pars compacta and ventral tegmental area, and cholinergic neurons in the medial septum and vertical limb of the diagonal band of Broca in 5-6.5-month and 20-26-month-old FBN rats of both sexes. Dopaminergic and cholinergic cell bodies were immunolabeled for tyrosine hydroxylase and choline acetyltransferase, respectively. Because the final counts were obtained from full-thickness image stacks using cell-profile inclusion rules and relatively sparse section sampling, these values are presented as stereological sampling-based estimates rather than strict design-based stereological totals. Within these methodological limits, no age differences in dopaminergic or cholinergic neuron-number estimates were detected in any region assessed, nor were there differences between males and females. These data suggest that FBN rats can be used to model induced age-related neurodegenerative disease without the potential confound of a large independent age-associated loss of these dopaminergic or cholinergic neuronal populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.